Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
GE Healthcare Launches High Performance Amersham™ Imager 600 Series
Monday, March 17, 2014
Superb imaging in chemiluminescence, fluorescence and colorimetric applications.

Princeton Instruments Camera Used to Measure 2D SFG Spectrum of a Peptide
Friday, March 14, 2014
Researchers at UW-Madison measure two-dimensional sum frequency generation spectrum using PIXIS:400B CCD camera.

Double O-ring Ensures High Integrity Cap Mat Seal
Thursday, March 13, 2014
New silicone cap mats from Porvair Sciences.

Merck Millipore Introduces the 2014 Predictable Protein Performance Virtual Conference
Friday, March 07, 2014
Company will hold the conference on March 26 and 27, 2014.

Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

Malvern Announces Guest Presenter for March 18th Protein Characterization Webinar
Thursday, March 06, 2014
Renowned protein scientist Prof. Dr. John F. Carpenter shows how combining DLS with Raman Spectroscopy delivers new insights in protein stability, aggregation and structure.

New HPLC Column Separates Challenging Glycan Isomers
Wednesday, March 05, 2014
Company will showcase the GlycanPac AXR-1 column at Pittcon 2014.

Abcam Introduces Alexa Fluor® 680/790 Secondary Antibodies
Tuesday, March 04, 2014
New range offers high performance antibodies for more efficient western blotting.

Malvern Instruments Shows NanoSight NTA at BioNanoMed 2014
Saturday, March 01, 2014
BioNanoMed 2014 to be held in Krems, Austria from 26 - 28 March.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1228
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv